Frontlight ResearchEarly access
CompletedNo phase
Retrospective Multicentre Study on the Impact of Neonatal Screening for Congenital Adrenal Hyperplasia in Italy
Key facts
- Who runs it
- IRCCS Azienda Ospedaliero-Universitaria di Bologna
- Where
- Italy4 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 29 people enrolled
- Started
- 23 Oct 2020
- Ended
- 15 Sept 2025
- Type of study
- Observational
- Record updated
- 12 March 2026
Who can take part
- Age
- Up to 18 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 4 criteriaShow less
Who can take part
- Neonatal who underwent neonatal screening for congenital adrenal hyperplasia between January 2006 and December 2019 at participating centres
- Patients diagnosed with Congenital Adrenal Hyperplasia
- Obtaining informed consent
Who cannot take part
- None
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Oservational, retrospective, multicenter study focused on neonatal screening for Congenital Adreanl Hyperplasia.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 12 March 2026